Friday, 24 February 2017

Pacific Edge Limited

NZX : PEB

0.5200
23 Feb 17 14:46
Change:
 0.03
Open:
0.5000
High:
0.5200
Ask:
0.5400
Volume:
96,278
Change(%):
5.05
Prev:
0.4950
Low:
0.4950
Bid:
0.5200
Avg vol:
0
Profile
Pacific Edge is a New Zealand based biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer.
Two products have recently completed successful clinical trials, bladder cancer detection and colorectal cancer prognosis (CRC). The bladder cancer technology Cxbladder® has been released to the market in Australia and New Zealand. CRC is being readied for commercial release. Pipeline products still in development include gastric and endometrial cancers and melanoma.
Cxbladder® is a non-invasive, accurate test that enables the early detection of bladder cancer from a small volume of urine providing general practitioners and urologists with a quick, cost effective and accurate measure of the presence of the cancer and provides urologists with the opportunity to reduce their reliance on the need for invasive tests such as cystoscopy.
The Company is commercialising its products from its new diagnostic laboratory in New Zealand and plans further commercialisation in the US and Europe as a centralised diagnostic service through its own facilities or as a turn-key solution, licensed to selected partners. Pacific Edge has plans for further studies in key markets to engage leading medical and urological opinion leaders who will be vital to success in new markets.
Summary
Shares:399,277,200
Issuer:Pacific Edge Limited
Solicitor:Anderson Lloyd Caudwell Dunedin
Registry:LINK MARKET SERVICES LIMITED
Auditor:Pricewaterhouse Coopers Dunedin
Settlement:NZCDC Settlement System
Website:http://www.peblnz.com/
Fundamentals
Market Cap:$207,624,144
52 wk High:0.6700
52 wk Low:0.3800
Sector:Investment
NTA:0.0260
Address
Pacific Edge Limited
87 St David Street
Dunedin 9016
New Zealand
Latest News
Announcements
  • SSH - Salt Funds Management Limited

    16:21 | 20/2/17
    NZX
    Disclosure of movement of 1% or more in substantial holding or change in nature of relevant interest, or both Sections 277 and 278, Financial Markets Conduct Act 2013 To NZX more»
  • SSH Notice - Westpac Banking Corporation

    17:15 | 17/2/17
    NZX
    Disclosure of movement of 1% or more in substantial holding or change in nature of relevant interest, or both Sections 277 and 278, Financial Markets Conduct Act 2013 To: NZX  more»
  • SSH - K One W One Limited

    15:57 | 17/2/17
    NZX
    Disclosure of ceasing to have substantial holding Section 279, Financial Markets Conduct Act 2013 Note: This form must be completed in accordance with the instructions at the more»
  • Notice of Issue of Shares under Private Placement

    15:19 | 17/2/17
    NZX
    NOTICE OF CHANGE IN ISSUED CAPITAL STOCK - ORDINARY SHARES Pursuant to NZX Listing Rule 7.3.5 Notice of Issue of Shares under Private Placement Company Pacific Edge Limite more»
  • Pacific Edge Undertakes $8m Share Placement

    09:07 | 15/2/17
    NZX
    15 February 2017 Pacific Edge Undertakes $8m Share Placement Capital Investment To Assist The Push Through To Cashflow Positive Position Cancer diagnostics company, Pacifi more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
Add a Comment
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
Global Indices
CodeLastChange
NZ507,090270.38%
COMP5,834270.46%
DJI20,821460.22%
SP5002,36300.00%
DAX11,948510.42%
FTSE7,271310.42%
NI22519,37180.04%
TWI77.790.220.29%
Currencies
CodeLastChange
EURUSD1.0590.0020.18%
NZDUSD0.72340.00360.50%
AUDUSD0.77150.00070.09%
NZDAUD0.93720.00350.37%